Below are the most recent publications written about "Health Care Costs" by people in Profiles.
-
Williams MM, Smith NR, Uyl-de Groot CA, den Uil CA, Ross JS, Mohamed MO, Mamas MA, Banerjee A, Ko DT, Landon B, Cram P. Variations in the Medical Device Authorization and Reimbursement Landscape: A Case Study of 2 Cardiovascular Devices Across 4 Countries. Circ Cardiovasc Qual Outcomes. 2025 Apr; 18(4):e011636.
-
Combs JC, Yamasaki MU, Dougherty M, Hunkler K, Osmundsen EB, Roura-Monllor J, Stillman RJ, Hill MJ, Devine K, DeCherney AH, Nelson RE, O'Brien JE. Comparing gestational carrier with uterine transplantation in uterine-factor infertility: a cost-effectiveness analysis. Fertil Steril. 2025 Jul; 124(1):134-143.
-
Mu Y, Dashtban A, Mizani MA, Tomlinson C, Mohamed M, Ashworth M, Mamas M, Priedon R, Petersen S, Kontopantelis E, Horstmanshof K, Pagel C, Hocaoglu M, Khunti K, Williams R, Thygesen J, Lorgelly P, Gomes M, Heightman M, Banerjee A. Healthcare utilisation of 282,080 individuals with long COVID over two years: a multiple matched control, longitudinal cohort analysis. J R Soc Med. 2024 11; 117(11):369-381.
-
King JB, Sakhuja S, Derington CG, Kolm P, Herrick JS, Berchie RO, Shen J, Greene T, Tajeu GS, Howard G, Levitan EB, Muntner P, Safford MM, Ying J, Weintraub WS, Moran AE, Bress AP, Bellows BK. Annual Cost of Implementing Intensive Systolic Blood Pressure Goals in the United States. J Am Heart Assoc. 2024 09 17; 13(18):e034515.
-
McNamara KC, Rudy ET, Rogers J, Goldberg ZN, Friedman HS, Navaratnam P, Nash DB. The Cost of Unhealthy Days: A New Value Assessment. Popul Health Manag. 2024 06; 27(5):307-311.
-
Merdler I, Wallace R, Hill AP, Chitturi KR, Medranda GA, Reddy P, Zhang C, Ozturk ST, Sawant V, Weintraub WS, Lopez K, Ben-Dor I, Waksman R, Hashim HD, Case BC. From chest pain to coronary functional testing: Clinical and economic impact of coronary microvascular dysfunction. Cardiovasc Revasc Med. 2024 09; 66:56-60.
-
Rappaport DI, Wilding KM, Adkins L, Bourque M, Miller JM. How Will a Shift to Value-Based Financial Models Affect Care for Hospitalized Children? Hosp Pediatr. 2024 03 01; 14(3):e177-e180.
-
Tajeu GS, Ruiz-Negr?n N, Moran AE, Zhang Z, Kolm P, Weintraub WS, Bress AP, Bellows BK. Cost of Cardiovascular Disease Event and Cardiovascular Disease Treatment-Related Complication Hospitalizations in the United States. Circ Cardiovasc Qual Outcomes. 2024 03; 17(3):e009999.
-
Weintraub WS, Bhatt DL, Zhang Z, Dolman S, Boden WE, Bress AP, Bellows BK, Derington CG, Philip S, Steg G, Miller M, Brinton EA, Jacobson TA, Tardif JC, Ballantyne CM, Kolm P. Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States. J Am Heart Assoc. 2024 01 02; 13(1):e032413.
-
Png ME, Mason KJ, Marshall M, Jordan KP, Bailey J, Frisher M, Heron N, Huntley AL, Mallen CD, Mamas MA, Tatton S, White S, Edwards JJ, Achana F. Estimating the direct healthcare utilization and cost of musculoskeletal pain among people with comorbidity: a retrospective electronic health record study. Curr Med Res Opin. 2023 11; 39(11):1473-1480.